一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Bioactive Materials >>article
Bioactive Materials

Bioactive Materials

IF: 18
Download PDF

Reprogramming exosomes for immunity-remodeled photodynamic therapy against non-small cell lung cancer

Published:21 May 2024 DOI: 10.1016/j.bioactmat.2024.05.030
Jiao Guo , Wei Zhao , Xinyu Xiao , Shanshan Liu , Liang Liu , La Zhang , Lu Li , Zhenghang Li , Zhi Li , Mengxia Xu , Qiling Peng , Jianwei Wang , Yuxian Wei , Ning Jiang

Abstract

Traditional treatments against advanced non-small cell lung cancer (NSCLC) with high morbidity and mortality continue to be dissatisfactory. Given this situation, there is an urgent requirement for alternative modalities that provide lower invasiveness, superior clinical effectiveness, and minimal adverse effects. The combination of photodynamic therapy (PDT) and immunotherapy gradually become a promising approach for high-grade malignant NSCLC. Nevertheless, owing to the absence of precise drug delivery techniques as well as the hypoxic and immunosuppressive characteristics of the tumor microenvironment (TME), the efficacy of this combination therapy approach is less than ideal. In this study, we construct a novel nanoplatform that indocyanine green (ICG), a photosensitizer, loads into hollow manganese dioxide (MnO2) nanospheres (NPs) (ICG@MnO2), and then encapsulated in PD-L1 monoclonal antibodies (anti-PD-L1) reprogrammed exosomes (named ICG@MnO2@Exo-anti-PD-L1), to effectively modulate the TME to oppose NSCLC by the synergy of PDT and immunotherapy modalities. The ICG@MnO2@Exo-anti-PD-L1 NPs are precisely delivered to the tumor sites by targeting specially PD-L1 highly expressed cancer cells to controllably release anti-PD-L1 in the acidic TME, thereby activating T cell response. Subsequently, upon endocytic uptake by cancer cells, MnO2 catalyzes the conversion of H2O2 to O2, thereby alleviating tumor hypoxia. Meanwhile, ICG further utilizes O2 to produce singlet oxygen (1O2) to kill tumor cells under 808?nm near-infrared (NIR) irradiation. Furthermore, a high level of intratumoral H2O2 reduces MnO2 to Mn2+, which remodels the immune microenvironment by polarizing macrophages from M2 to M1, further driving T cells. Taken together, the current study suggests that the ICG@MnO2@Exo-anti-PD-L1 NPs could act as a novel drug delivery platform for achieving multimodal therapy in treating NSCLC.

Similar articles

IF:3

A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer

Saudi Pharmaceutical Journal Silky Bedi , Shah A. Khan ,etc Published: 1 September 2018
IF:12.7

Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.

ACS Central Science Sabrina Baltschukat, Barbara Schacher Engstler,etc Published: 15 May 2019
英山县| 平江县| 吉安市| 准格尔旗| 镇江市| 汾西县| 上栗县| 富平县| 永州市| 中山市| 中山市| 乐山市| 尉氏县| 信丰县| 宜丰县| 虎林市| 安新县| 邯郸县| 静乐县| 报价| 宕昌县| 临泉县| 邯郸县| 洱源县| 佛坪县| 景德镇市| 宜阳县| 迁安市| 黄浦区| 克东县| 永川市| 胶州市| 吉隆县| 峨山| 雅安市| 定兴县| 泸溪县| 沙湾县| 萝北县| 新建县| 新安县|